EGFR and chronic obstructive pulmonary disease: Our studies focus on two ADAM17 substrates implicated in COPD pathogenesis: the IL‐6 cytokine receptor (IL6R) and the growth factor amphiregulin (AREG), one of the EGFR agonists produced by bronchial epithelial cells (Richter et al.